NPA List

 

Aliri brings more than 30 years of experience in bioanalytical services, developing robust methods to support all stages of drug discovery and development.  We offer an extensive list of validated, off-the-shelf assays you can leverage to support a range of research applications.  In addition to the hundreds of assays listed below, Aliri also excels at developing customized methods to meet your specific challenges.

Download Now

Coproporphyrin-I and Coproporphyrin-III

 

Aliri Bioanalysis presents a newly validated non-proprietary biomarker assay (NPA) for the quantitation of Coproporphyrin I and Coproporphyrin III in human plasma. This assay offers significant advancements in biomarker analysis, applicable across diagnostics, pharmaceutical research, and patient care.

By monitoring these biomarkers, particularly in early clinical development, companies can assess OATP1B1 inhibition, potentially avoiding the need for dedicated clinical drug-drug interaction studies, saving both time and money.

Learn more about the benefits of our NPA for Coproporphyrin I and Coproporphyrin III.

Download Now

LC/MS/MS VS. LC/HRMS: Identifying and quantifying oligonucleotides 

 

LC/MS/MS and LC/HRMS are formidable instruments employed in mass spectrometry for the identification and quantification of Oligonucleotides (OGNTs). Utilizing these approaches, drug developers can obtain detailed insights into the composition and structure of molecules for biotechnology and pharmaceuticals.

Considerations for choosing the right approach for your drug development project will depend on: 

  • What instrument you have 
  • Where you want to go 
  • How much information you want to collect in a single injection 

Discover which technique is best for you.

Download Now

Optimizing small molecule drug development strategies: A step by step approach to a rugged method


Creating a rugged method for the development of small molecule drugs is crucial in the quest for successful therapies. A systematic approach not only guarantees data consistency and reliability but also empowers you to make well-informed decisions, ultimately boosting project efficiency and success.

To help you navigate the complexities and uncertainties that come with advancing small molecules for drug development, we’ve outlined a robust strategy that includes 7 crucial steps.

Download our fact sheet to learn more.

Download Now